Trials / Conditions / Advanced KRAS G12D Mutant Solid Tumors
Advanced KRAS G12D Mutant Solid Tumors
3 registered clinical trials studyying Advanced KRAS G12D Mutant Solid Tumors — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07134998 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Active Not Recruiting | A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation NCT06385678 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | Phase I Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation NCT05533463 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |